Pediatric-type nodal follicular lymphoma: A biologically distinct lymphoma with frequent MAPK pathway mutations

Blood

Volumn 128, Issue 8, 2016, Pages 1093-1100

  Louissaint, Abner ^a,b   Schafernak, Kristian T ^c   Geyer, Julia T ^d   Kovach, Alexandra E ^e   Ghandi, Mahmoud ^f   Gratzinger, Dita ^g   Roth, Christine G ^h   Paxton, Christian N ⁱ   Kim, Sunhee ^b   Namgyal, Chungdak ^j   Morin, Ryan ^k   Morgan, Elizabeth A ^j   Neuberg, Donna S ^b   South, Sarah T ^l   Harris, Marian H ^e   Hasserjian, Robert P ^a   Hochberg, Ephraim P ^a   Garraway, Levi A ^b,f   Harris, Nancy Lee ^a   Weinstock, David M ^b,f  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c CHILDREN'S MEMORIAL HOSPITAL   (United States)

^d NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^e BOSTON CHILDREN S HOSPITAL   (United States)

^f MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^g STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

ⁱ ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY   (United States)

^j BRIGHAM AND WOMEN S HOSPITAL   (United States)

^k SIMON FRASER UNIVERSITY   (Canada)

^l ARUP LABORATORIES   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DUAL SPECIFICITY PHOSPHATASE 6; HERPESVIRUS ENTRY MEDIATOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN BCL 2; PROTEIN BCL 6; SUPPRESSOR OF CYTOKINE SIGNALING 1;

ADULT; AGED; ARTICLE; CHILD; CHILDHOOD CANCER; CHROMOSOME DELETION X; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVE SITE; EXON; FAILURE FREE SURVIVAL; FEMALE; FOLLICULAR LYMPHOMA; GENE REARRANGEMENT; GENETIC CONSERVATION; HETEROZYGOSITY LOSS; HUMAN; IN SITU HYBRIDIZATION; LARGE CELL LYMPHOMA; MALE; MISSENSE MUTATION; MODIFIER GENE; MUTATION RATE; NEXT GENERATION SEQUENCING; PEDIATRIC TYPE NODAL FOLLICULAR LYMPHOMA; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SOMATIC MUTATION; ADOLESCENT; AGE; CELL SHAPE; COPY NUMBER VARIATION; ENZYMOLOGY; GENETIC EPIGENESIS; GENETICS; IMMUNOPHENOTYPING; INFANT; MUTATION; PATHOLOGY; PRESCHOOL CHILD; SIGNAL TRANSDUCTION;

ADOLESCENT; AGE FACTORS; CELL SHAPE; CHILD; CHILD, PRESCHOOL; DNA COPY NUMBER VARIATIONS; EPIGENESIS, GENETIC; FEMALE; HUMANS; IMMUNOPHENOTYPING; INFANT; LYMPHOMA, FOLLICULAR; MALE; MAP KINASE SIGNALING SYSTEM; MUTATION;

EID: 84984670470     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2015-12-682591     Document Type: Article

References (31)

1. Liu Q, Salaverria I, Pittaluga S, et al. Follicular lymphomas in children and young adults: a comparison of the pediatric variant with usual follicular lymphoma. Am J Surg Pathol. 2013;37(3):333-343.
2. Louissaint A Jr, Ackerman AM, Dias-Santagata D, et al. Pediatric-type nodal follicular lymphoma: an indolent clonal proliferation in children and adults with high proliferation index and no BCL2 rearrangement. Blood. 2012;120(12):2395-2404.
3. Attarbaschi A, Beishuizen A, Mann G, et al; European Intergroup for Childhood Non-Hodgkin Lymphoma (EICNHL) and the international Berlin-Frankfurt-Münster (i-BFM) Study Group. Children and adolescents with follicular lymphoma have an excellent prognosis with either limited chemotherapy or with a "Watch and wait" strategy after complete resection. Ann Hematol. 2013;92(11):1537-1541.
4. Cheung KJ, Johnson NA, Affleck JG, et al. Acquired TNFRSF14 mutations in follicular lymphoma are associated with worse prognosis. Cancer Res. 2010;70(22):9166-9174.
5. Morin RD, Johnson NA, Severson TM, et al. Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nat Genet. 2010;42(2):181-185.
6. Annibali O, Romeo AA, Agostinelli C, et al. A case of primary MALT lymphoma of the endometrium presenting as an asymptomatic polyp. Ann Hematol. 2009;88(5):491-493.
7. Wright TM, Rule S, Liu H, Du MQ, Smith ME. Extranodal marginal zone lymphoma of the uterine corpus. Leuk Lymphoma. 2012;53(9):1831-1834.
8. Ryan RJ, Nitta M, Borger D, et al. EZH2 codon 641 mutations are common in BCL2-rearranged germinal center B cell lymphomas. PLoS One. 2011;6(12):e28585.
9. Iyengar P, Deodhare S. Primary extranodal marginal zone B-cell lymphoma of MALT type of the endometrium. Gynecol Oncol. 2004;93(1):238-241.
10. Heeren JH, Croonen AM, Pijnenborg JM. Primary extranodal marginal zone B-cell lymphoma of the female genital tract: a case report and literature review. Int J Gynecol Pathol. 2008;27(2):243-246.
11. Guo S, Chan JK, Iqbal J, et al. EZH2 mutations in follicular lymphoma from different ethnic groups and associated gene expression alterations. Clin Cancer Res. 2014;20(12):3078-3086.
12. Karube K, Martínez D, Royo C, et al. Recurrent mutations of NOTCH genes in follicular lymphoma identify a distinctive subset of tumours. J Pathol. 2014;234(3):423-430.
13. Frey NV, Svoboda J, Andreadis C, et al. Primary lymphomas of the cervix and uterus: the University of Pennsylvania's experience and a review of the literature. Leuk Lymphoma. 2006;47(9):1894-1901.
14. Hamadani M, Kharfan-Dabaja M, Kamble R, Kern W, Ozer H. Marginal zone B-cell lymphoma of the uterus: a case report and review of the literature. J Okla State Med Assoc. 2006;99(4):154-156.
15. Pasqualucci L, Khiabanian H, Fangazio M, et al. Genetics of follicular lymphoma transformation. Cell Rep. 2014;6(1):130-140.
16. Yildiz M, Li H, Bernard D, et al. Activating STAT6 mutations in follicular lymphoma. Blood. 2015;125(4):668-679.
17. Chapman MA, Lawrence MS, Keats JJ, et al. Initial genome sequencing and analysis of multiple myeloma. Nature. 2011;471(7339):467-472.
18. Gnirke A, Melnikov A, Maguire J, et al. Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing. Nat Biotechnol. 2009;27(2):182-189.
19. Wagle N, Berger MF, Davis MJ, et al. High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing. Cancer Discov. 2012;2(1):82-93.
20. Odejide O, Weigert O, Lane AA, et al. A targeted mutational landscape of angioimmunoblastic T-cell lymphoma. Blood. 2014;123(9):1293-1296.
21. Lane AA, Odejide O, Kopp N, et al. Low frequency clonal mutations recoverable by deep sequencing in patients with aplastic anemia. Leukemia. 2013;27(4):968-971.
22. Chakraborty R, Hampton OA, Shen X, et al. Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis. Blood. 2014;124(19):3007-3015.
23. Vang R, Medeiros LJ, Ha CS, Deavers M. Non-Hodgkin's lymphomas involving the uterus: a clinicopathologic analysis of 26 cases. Mod Pathol. 2000;13(1):19-28.
24. Collette Y, Gilles A, Pontarotti P, Olive D. A coevolution perspective of the TNFSF and TNFRSF families in the immune system. Trends Immunol. 2003;24(7):387-394.
25. Brown NA, Furtado LV, Betz BL, et al. High prevalence of somatic MAP2K1 mutations in BRAF V600E-negative Langerhans cell histiocytosis. Blood. 2014;124(10):1655-1658.
26. Alayed K, Medeiros LJ, Patel KP, et al. BRAF and MAP2K1 mutations in Langerhans cell histiocytosis: a study of 50 cases. Hum Pathol. 2016;52:61-67.
27. Waterfall JJ, Arons E, Walker RL, et al. High prevalence of MAP2K1 mutations in variant and IGHV4-34-expressing hairy-cell leukemias. Nat Genet. 2014;46(1):8-10.
28. Cave H. Gene symbol: MAP2K1. Disease: cardiofacio-cutaneous syndrome. Hum Genet. 2008;123(5):551.
29. da Silva Almeida AC, Abate F, Khiabanian H, et al. The mutational landscape of cutaneous T cell lymphoma and Sézary syndrome. Nat Genet. 2015;47(12):1465-1470.
30. Flex E, Jaiswal M, Pantaleoni F, et al. Activating mutations in RRAS underlie a phenotype within the RASopathy spectrum and contribute to leukaemogenesis. Hum Mol Genet. 2014;23(16):4315-4327.
31. Harris NL, Swerdlow SH, Jaffe ES, et al. Follicular lymphoma. In: Swerdlow SH, Campo E, Harris NL, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC; 2008:220-226.